Ikenna Madu

Ikenna Madu currently serves as the Director of Alliance Management at Recursion, a prominent TechBio company focused on innovative drug discovery. In this role, Madu emphasizes the importance of partnerships within Recursion's business model. Additionally, Madu is a member of the Healthcare Investment Committee at Nubia Capital, supporting African entrepreneurs in tech-enabled business growth. Previous experience includes positions at Lyell Immunopharma as Associate Director of Alliance Management, where Madu led oncology partnerships, and at Oregon Health & Science University as Program Director and Senior Manager in Strategic Alliance and Business Development, managing industry collaborations in precision oncology. Earlier roles encompass venture analysis at Washington Research Foundation and senior scientific positions at Kineta, Inc., City of Hope, and Cornell University. Madu holds a Ph.D. in Biochemistry, Molecular and Cell Biology from Cornell University, an MBA in Marketing from WSU Carson College of Business, and a Bachelor's Degree in Biochemistry from California State University, Los Angeles.